Lantheus Holdings [LNTH] vs Zoetis [ZTS] Detailed Stock Comparison
Lantheus Holdings
NASDAQ
Loading...
Zoetis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lantheus Holdings wins in 9 metrics, Zoetis wins in 10 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lantheus Holdings | Zoetis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.89 | 25.36 | Lantheus Holdings |
| Price-to-Book Ratio | 3.26 | 13.14 | Lantheus Holdings |
| Debt-to-Equity Ratio | 52.75 | 137.01 | Lantheus Holdings |
| PEG Ratio | 0.51 | 23.24 | Lantheus Holdings |
| EV/EBITDA | 7.54 | 17.91 | Lantheus Holdings |
| Profit Margin (TTM) | 17.82% | 27.83% | Zoetis |
| Operating Margin (TTM) | 23.27% | 40.20% | Zoetis |
| EBITDA Margin (TTM) | 23.27% | 40.20% | Zoetis |
| Return on Equity | 24.71% | 52.77% | Zoetis |
| Return on Assets (TTM) | 13.34% | 15.37% | Zoetis |
| Free Cash Flow (TTM) | $465.13M | $2.30B | Zoetis |
| Dividend Yield | N/A | 1.11% | N/A |
| 1-Year Return | -44.79% | -16.11% | Zoetis |
| Price-to-Sales Ratio (TTM) | 2.50 | 6.96 | Lantheus Holdings |
| Enterprise Value | $3.73B | $70.67B | Zoetis |
| EV/Revenue Ratio | 2.45 | 7.53 | Lantheus Holdings |
| Gross Profit Margin (TTM) | 63.75% | 73.62% | Zoetis |
| Revenue per Share (TTM) | $22 | $21 | Lantheus Holdings |
| Earnings per Share (Diluted) | $3.76 | $5.81 | Zoetis |
| Beta (Stock Volatility) | 0.14 | 0.88 | Lantheus Holdings |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lantheus Holdings vs Zoetis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lantheus Holdings | -1.56% | 8.61% | -17.33% | -21.26% | -24.38% | -33.38% |
| Zoetis | 1.51% | 4.59% | 0.82% | -3.89% | -1.51% | -5.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lantheus Holdings | -44.79% | -27.42% | 338.55% | 776.44% | 820.06% | 820.06% |
| Zoetis | -16.11% | -9.09% | -2.69% | 242.31% | 396.97% | 396.97% |
Performance & Financial Health Analysis: Lantheus Holdings vs Zoetis
| Metric | LNTH | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $3.81B | $65.30B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 3,414,760 | 4,111,510 |
| 90 Day Avg. Volume | 1,859,730 | 3,459,870 |
| Last Close | $58.24 | $167.10 |
| 52 Week Range | $47.25 - $118.21 | $139.70 - $200.33 |
| % from 52W High | -50.73% | -16.59% |
| All-Time High | $126.89 (Jul 15, 2024) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -54.10% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.04% | 0.04% |
| Quarterly Earnings Growth | 0.27% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.28% |
| Operating Margin (TTM) | 0.23% | 0.40% |
| Return on Equity (TTM) | 0.25% | 0.53% |
| Debt to Equity (MRQ) | 52.75 | 137.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $17.16 | $11.21 |
| Cash per Share (MRQ) | $10.23 | $3.28 |
| Operating Cash Flow (TTM) | $527.46M | $2.93B |
| Levered Free Cash Flow (TTM) | $295.47M | $2.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.11% |
| Last 12-Month Dividend | N/A | $1.86 |
Valuation & Enterprise Metrics Analysis: Lantheus Holdings vs Zoetis
| Metric | LNTH | ZTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.89 | 25.36 |
| Forward P/E | 8.08 | 23.24 |
| PEG Ratio | 0.51 | 23.24 |
| Price to Sales (TTM) | 2.50 | 6.96 |
| Price to Book (MRQ) | 3.26 | 13.14 |
| Market Capitalization | ||
| Market Capitalization | $3.81B | $65.30B |
| Enterprise Value | $3.73B | $70.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.45 | 7.53 |
| Enterprise to EBITDA | 7.54 | 17.91 |
| Risk & Other Metrics | ||
| Beta | 0.14 | 0.88 |
| Book Value per Share (MRQ) | $17.16 | $11.21 |
Financial Statements Comparison: Lantheus Holdings vs Zoetis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LNTH | ZTS |
|---|---|---|
| Revenue/Sales | $372.76M | $2.22B |
| Cost of Goods Sold | $135.06M | $622.00M |
| Gross Profit | $237.70M | $1.60B |
| Research & Development | $36.31M | $157.00M |
| Operating Income (EBIT) | $106.79M | $846.00M |
| EBITDA | $129.90M | $991.00M |
| Pre-Tax Income | $96.53M | $810.00M |
| Income Tax | $23.58M | $179.00M |
| Net Income (Profit) | $72.95M | $631.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LNTH | ZTS |
|---|---|---|
| Cash & Equivalents | $938.53M | $1.72B |
| Total Current Assets | $1.42B | $5.88B |
| Total Current Liabilities | $248.00M | $3.39B |
| Long-Term Debt | $613.66M | $5.40B |
| Total Shareholders Equity | $1.16B | $4.66B |
| Retained Earnings | $518.89M | $12.38B |
| Property, Plant & Equipment | $0 | $6.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LNTH | ZTS |
|---|---|---|
| Operating Cash Flow | $95.48M | $567.00M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $98.85M | $438.00M |
| Debt Repayment | $-402,000 | N/A |
| Common Stock Repurchase | N/A | $-443.00M |
Short Interest & Institutional Ownership Analysis
| Metric | LNTH | ZTS |
|---|---|---|
| Shares Short | 8.42M | 7.85M |
| Short Ratio | 8.25 | 2.67 |
| Short % of Float | 0.16% | 0.02% |
| Average Daily Volume (10 Day) | 3,414,760 | 4,111,510 |
| Average Daily Volume (90 Day) | 1,859,730 | 3,459,870 |
| Shares Outstanding | 68.45M | 448.47M |
| Float Shares | 59.94M | 442.37M |
| % Held by Insiders | 0.02% | 0.00% |
| % Held by Institutions | 1.22% | 0.98% |
Dividend Analysis & Yield Comparison: Lantheus Holdings vs Zoetis
| Metric | LNTH | ZTS |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.86 |
| Last 12-Month Dividend Yield | N/A | 1.11% |
| 3-Year Avg Annual Dividend | N/A | $1.63 |
| 3-Year Avg Dividend Yield | N/A | 0.24% |
| 3-Year Total Dividends | N/A | $4.90 |
| Ex-Dividend Date | N/A | Apr 21, 2025 |